From Our Archives: Advocacy
September 14, 2011
Cancer Imaging Gets Sophisticated
September 14, 2011 – Susan R. Peck, PhD
Sleep Problems Impair Childhood Cancer Survivors
September 14, 2011 – Taylor Walker
Vitamin D and Folate May Reduce Colon Cancer Risk
September 14, 2011 – Lena Huang
From Our Archives: Supplements
September 14, 2011
From Our Archives: Imaging
September 16, 2011
Flaxseed Doesn't Help With Hot Flashes
September 14, 2011 – Kathy LaTour
Safety in Numbers
September 14, 2011 – Jane Hill
Previvors Need Expert Guidance, Close Surveillance
September 14, 2011 – Dawn Dorsey
Should You “Just Do It?”
September 14, 2011 – Marc Silver
Checking Out a Charity
September 14, 2011 – Marc Silver
Understanding Clinical Trials
September 14, 2011
Don’t Believe Everything You Read on Supplement Labels
September 14, 2011 – Laura Beil
Tell What You’re Taking
September 14, 2011 – Laura Beil
Searching for a Cancer Coach?
September 14, 2011 – Jennifer M. Gangloff
What Caused Your Cancer?
September 14, 2011 – Staff Reports
Açaí Berry’s Effect on Cancer in Question
September 14, 2011 – Jason Roberson
Remaining Faithful
September 14, 2011 – Cheryl L. Rice
Pipeline
September 14, 2011 – Lindsay Ray
Supplement Research in Cancer Lacking
September 14, 2011 – Barrie Cassileth, PhD
Managing Cancer-Related Diarrhea
September 14, 2011 – Katy Human
Comments from Readers
September 14, 2011
The Meaning of Stem Cells
September 14, 2011 – Debu Tripathy, MD
San Antonio Breast Cancer Symposium
September 14, 2011 – Lindsay Ray
Q & A: Patients Want Coordinated Care
September 14, 2011 – Len Lichtenfeld, MD
A Survivorship Resource Map
September 14, 2011 – Elizabeth Whittington
Critical Care: A New Nurse Faces Death, Life, and Everything in Between
September 14, 2011 – Kathy LaTour
Breast Cancer Drug Scores Win in Prevention
September 14, 2011 – Elizabeth Whittington
Ford Led Discussion on Breast Cancer
September 14, 2011 – Lindsay Ray
Another State Gets Chemo Parity
September 14, 2011 – Taylor Walker
How to Manage Family Dynamics During Cancer
September 14, 2011 – Jane Hill
Coordinating Care After Cancer
September 14, 2011 – Dawn Dorsey
Do You Need a Cancer Coach?
September 14, 2011 – Jennifer M. Gangloff
Choosing an Imaging Test
September 14, 2011 – Charlotte Huff
Advocates Make Cancer Their Mission
September 14, 2011 – Marc Silver
Unlocking the Mystery of Cancer Stem Cells
September 14, 2011 – Elaine Schattner, MD
Supplements During Cancer: Help or Hype?
September 14, 2011 – Laura Beil
From Our Archives: Advocacy
September 14, 2011
Currently Viewing
Cancer Imaging Gets Sophisticated
September 14, 2011 – Susan R. Peck, PhD
Vitamin D and Folate May Reduce Colon Cancer Risk
September 14, 2011 – Lena Huang
From Our Archives: Supplements
September 14, 2011
From Our Archives: Imaging
September 16, 2011
Flaxseed Doesn't Help With Hot Flashes
September 14, 2011 – Kathy LaTour
Safety in Numbers
September 14, 2011 – Jane Hill
Previvors Need Expert Guidance, Close Surveillance
September 14, 2011 – Dawn Dorsey
Should You “Just Do It?”
September 14, 2011 – Marc Silver
Checking Out a Charity
September 14, 2011 – Marc Silver
Understanding Clinical Trials
September 14, 2011
Don’t Believe Everything You Read on Supplement Labels
September 14, 2011 – Laura Beil
Tell What You’re Taking
September 14, 2011 – Laura Beil
Searching for a Cancer Coach?
September 14, 2011 – Jennifer M. Gangloff
What Caused Your Cancer?
September 14, 2011 – Staff Reports
Açaí Berry’s Effect on Cancer in Question
September 14, 2011 – Jason Roberson
Remaining Faithful
September 14, 2011 – Cheryl L. Rice
Pipeline
September 14, 2011 – Lindsay Ray
Supplement Research in Cancer Lacking
September 14, 2011 – Barrie Cassileth, PhD
Managing Cancer-Related Diarrhea
September 14, 2011 – Katy Human
Comments from Readers
September 14, 2011
The Meaning of Stem Cells
September 14, 2011 – Debu Tripathy, MD
San Antonio Breast Cancer Symposium
September 14, 2011 – Lindsay Ray
Q & A: Patients Want Coordinated Care
September 14, 2011 – Len Lichtenfeld, MD
A Survivorship Resource Map
September 14, 2011 – Elizabeth Whittington
Critical Care: A New Nurse Faces Death, Life, and Everything in Between
September 14, 2011 – Kathy LaTour
Breast Cancer Drug Scores Win in Prevention
September 14, 2011 – Elizabeth Whittington
Ford Led Discussion on Breast Cancer
September 14, 2011 – Lindsay Ray
Another State Gets Chemo Parity
September 14, 2011 – Taylor Walker
How to Manage Family Dynamics During Cancer
September 14, 2011 – Jane Hill
Coordinating Care After Cancer
September 14, 2011 – Dawn Dorsey
Do You Need a Cancer Coach?
September 14, 2011 – Jennifer M. Gangloff
Choosing an Imaging Test
September 14, 2011 – Charlotte Huff
Advocates Make Cancer Their Mission
September 14, 2011 – Marc Silver
Unlocking the Mystery of Cancer Stem Cells
September 14, 2011 – Elaine Schattner, MD
Supplements During Cancer: Help or Hype?
September 14, 2011 – Laura Beil

Cancer Imaging Gets Sophisticated

The next generation of cancer imaging

BY Susan R. Peck, PhD
PUBLISHED September 14, 2011

While today’s imaging tests provide anatomical information about a tumor’s size and location, tomorrow’s imaging technologies will look deeper, at the molecular make-up of cancer cells.

Some potential uses for these more advanced technologies include detecting and characterizing cancers without the need for biopsies or other invasive procedures, ensuring that drugs are reaching the tumor and promptly monitoring the effect of therapies so treatment can be changed if necessary.

Positron emission tomography (PET) is leading the way in the molecular imaging revolution. Currently, in oncology most PET imaging is performed with a radioactively-labeled form of glucose, a type of sugar, called 18F-fluorodeoxyglucose, or simply FDG. Cancer cells, particularly those from aggressive tumors, metabolize significantly larger amounts of glucose than surrounding normal tissue. FDG-PET imaging measures glucose uptake, revealing how active a cancer is and detecting whether the cancer has spread beyond its original location.

Glucose metabolism is not unique to cancer cells; however, and not all cancers exhibit high metabolic rates, so researchers are working on developing agents that are much more specific. For example, scientists are studying how to detect when cells are dividing quickly or when they are dying as a means of determining whether a cancer treatment is effective. Others are looking at ways to target proteins on the surface of cancer cells, such as the HER2 receptor, the epidermal growth factor receptor (EGFR) or the estrogen and androgen receptors. Finding out whether the expression of these receptors increase or decrease when a cancer spreads may eliminate the need for repeated biopsies and allow therapies to be tailored to the individual cancer at each stage.

New agents are also being developed to visualize angiogenesis, or growth of blood vessels within and around tumors. This research may be useful in monitoring whether antiangiogenic therapies are working, or identifying which patients might best benefit from such therapy.

According to David M. Schuster, MD, director of nuclear medicine and molecular imaging at Emory University Hospital, “all of these agents are just experimental right now and studies are being done, but I think these new agents, especially coupled with advanced devices, may hold promise in the future – maybe not for mass screening, but in problem-solving situations and in helping to individualize therapy.”

Also on the horizon: molecularly-targeted dyes and probes that can work with common optical imaging systems. Fluorescent dyes that attach to proteins found on cancer cells are being tested with specially modified microscopes for use in screening procedures, such as colonoscopy or endoscopy. These dyes may be able to determine more quickly if an abnormal growth is cancerous.

In one early test, a colon cancer-specific dye showed a high degree of sensitivity and specificity for detecting cancerous cells in the colon. Another promising light-based technique uses a light source to create a high resolution, cross-sectional or three-dimensional image that can “see” 1 to 2 millimeters below the surface. The technique, called optical coherence tomography (OCT), is being investigated for the identification and surveillance of Barrett’s esophagus. Imaging tests like these could also be used for other cancers that can be reached with endoscopes or catheters, such as esophageal or bladder cancers.

Ultrasound and magnetic resonance imaging (MRI) tests are also getting upgrades. Non-specific contrast agents are currently used in contrast-enhanced endoscopic ultrasound to increase the ability of ultrasound to visualize tumors with low blood flow, such as pancreatic cancers. Now, next-generation molecularly targeted “microbubbles” are being designed to visualize disease-specific molecules in blood vessels and could be used to monitor response to antiangiogenic therapies. Likewise, molecularly-targeted magnetic particles are being developed for use with MRI.

“I think the most exciting area, though, is hybrid technology, where we take anatomic imaging techniques, such as MRI, and bring them together with molecular techniques,” Schuster says. “For example, combine mammography, say tomosynthesis, with using radiotracers—and these are all other areas, which also have great promise.”

Other hybrid techniques that are being tested include PET-MRI, which was recently cleared for use in June by the Food and Drug Administration, single-photon emission computed tomography (SPECT)-CT and MRI combined with optical fluorescence technology.

Although most of these techniques are still experimental, researchers are hopeful that advances in imaging detection systems will further improve the lives of patients with cancer through earlier detection, when the cancer is at a more curable stage, as well as better management and personalization of treatment for cancers at a more advanced stage.

Be the first to discuss this article on CURE's forum. >>
Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.

Related Articles

1
×

Sign In

Not a member? Sign up now!
×

Sign Up

Are you a member? Please Log In